Bibliografías temáticas / Recurrent brief depression

Índice

  1. Artículos de revistas
  2. Tesis
  3. Capítulos de libros
  4. Actas de conferencias

Literatura académica sobre el tema "Recurrent brief depression"

Autor: Grafiati
Publicado: 4 de junio de 2021
Última modificación: 11 de febrero de 2022

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Recurrent brief depression".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Recurrent brief depression"

1

Kasper, Siegfried, Mara Stamenkovic y Gabriele Fischer. "Recurrent Brief Depression". CNS Drugs 4, n.º 3 (septiembre de 1995): 222–29. http://dx.doi.org/10.2165/00023210-199504030-00006.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Pezawas, Lukas, Jules Angst y Siegfried Kasper. "Recurrent brief depression revisited". International Review of Psychiatry 17, n.º 1 (febrero de 2005): 63–70. http://dx.doi.org/10.1080/00207390500064650.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Koponen, Hannu, Ulla Lepola y Esa Leinonen. "Recurrent brief depression: A review". Nordic Journal of Psychiatry 49, n.º 1 (enero de 1995): 39–41. http://dx.doi.org/10.3109/08039489509011882.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

ANGST, J. "COMORBIDITY OF RECURRENT BRIEF DEPRESSION". Clinical Neuropharmacology 15 (1992): 9A—10A. http://dx.doi.org/10.1097/00002826-199201001-00004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Joffe, R. T. "Tranylcypromine in recurrent brief depression". International Clinical Psychopharmacology 11, n.º 4 (diciembre de 1996): 287–88. http://dx.doi.org/10.1097/00004850-199612000-00012.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Stamenkovic, M., L. Pezawas, M. de Zwaan, H. N. Aschauer y S. Kasper. "Mirtazapine in recurrent brief depression". International Clinical Psychopharmacology 13, n.º 1 (enero de 1998): 39–40. http://dx.doi.org/10.1097/00004850-199801000-00006.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Merikangas, Kathleen Ries, Werner Wicki y Jules Angst. "Heterogeneity of Depression". British Journal of Psychiatry 164, n.º 3 (marzo de 1994): 342–48. http://dx.doi.org/10.1192/bjp.164.3.342.

Texto completo
Resumen
This paper describes the application of prospective longitudinal data from an epidemiological sample of young adults to define subtypes of major depression. Depression was classified on a spectrum from subthreshold manifestation of symptoms and duration at one end, to cases with recurrent episodes of depression meeting duration criteria for major depressive episodes at the other. There was a direct relationship between the severity of depression over the longitudinal course and both duration and recurrence of depressive episodes. The subgroup of depression with recurrence of both brief and longer duration episodes could be discriminated on most of the indicators of validity including symptoms, impairment, family history, and suicide attempts. In light of the young age of this cohort, the strong history of suicide attempts and other complications of depression among the subjects with recurrent depression was striking. These findings underscore the importance of employing course as a classification criterion of depression, and the inclusion of subthreshold episodes of depression in the characterisation of course.
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Angst, J. "Recurrent Brief Depression. A New Concept of Depression". Pharmacopsychiatry 23, n.º 02 (marzo de 1990): 63–66. http://dx.doi.org/10.1055/s-2007-1014484.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Stamenkovic, M., L. Pezawas, H. N. Aschauer, M. de Zwaan y S. Kasper. "Mirtazapine in recurrent brief depression (RBD)". Biological Psychiatry 42, n.º 1 (julio de 1997): 242S. http://dx.doi.org/10.1016/s0006-3223(97)87906-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Carta, Mauro Giovanni, Maria Carolina Hardoy, Paolo Usai, Bernardo Carpiniello y Jules Angst. "Recurrent brief depression in celiac disease". Journal of Psychosomatic Research 55, n.º 6 (diciembre de 2003): 573–74. http://dx.doi.org/10.1016/s0022-3999(03)00547-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Recurrent brief depression"

1

Pezawas, Lukas, Hans-Ulrich Wittchen, Hildegard Pfister, Jules Angst, Roselind Lieb y Siegfried Kasper. "Recurrent brief depressive disorder reinvestigated : a community sample of adolescents and young adults". Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2013. http://nbn-resolving.de/urn:nbn:de:bsz:14-qucosa-103626.

Texto completo
Resumen
Background: This article presents prospective lower bound estimations of findings on prevalence, incidence, clinical correlates, severity markers, co-morbidity and course stability of threshold and subthreshold recurrent brief depressive disorder (RBD) and other mood disorders in a community sample of 3021 adolescents. Method: Data were collected at baseline (age 14–17) and at two follow-up interviews within an observation period of 42 months. Diagnostic assessment was based on the Munich Composite International Diagnostic Interview (M-CIDI). Results: Our data suggest that RBD is a prevalent (2.6%) clinical condition among depressive disorders (21.3%) being at least as prevalent as dysthymia (2.3%) in young adults over lifetime. Furthermore, RBD is associated with significant clinical impairment sharing many features with major depressive disorder (MDD). Suicide attempts were reported in 7.8% of RBD patients, which was similar to MDD (11.9%). However, other features, like gender distribution or co-morbidity patterns, differ essentially from MDD. Furthermore, the lifetime co-occurrence of MDD and RBD or combined depression represents a severe psychiatric condition. Conclusions: This study provides further independent support for RBD as a clinically significant syndrome that could not be significantly explained as a prodrome or residual of major affective disorders.
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Pezawas, Lukas, Hans-Ulrich Wittchen, Hildegard Pfister, Jules Angst, Roselind Lieb y Siegfried Kasper. "Recurrent brief depressive disorder reinvestigated : a community sample of adolescents and young adults". Cambridge University Press, 2003. https://tud.qucosa.de/id/qucosa%3A26457.

Texto completo
Resumen
Background: This article presents prospective lower bound estimations of findings on prevalence, incidence, clinical correlates, severity markers, co-morbidity and course stability of threshold and subthreshold recurrent brief depressive disorder (RBD) and other mood disorders in a community sample of 3021 adolescents. Method: Data were collected at baseline (age 14–17) and at two follow-up interviews within an observation period of 42 months. Diagnostic assessment was based on the Munich Composite International Diagnostic Interview (M-CIDI). Results: Our data suggest that RBD is a prevalent (2.6%) clinical condition among depressive disorders (21.3%) being at least as prevalent as dysthymia (2.3%) in young adults over lifetime. Furthermore, RBD is associated with significant clinical impairment sharing many features with major depressive disorder (MDD). Suicide attempts were reported in 7.8% of RBD patients, which was similar to MDD (11.9%). However, other features, like gender distribution or co-morbidity patterns, differ essentially from MDD. Furthermore, the lifetime co-occurrence of MDD and RBD or combined depression represents a severe psychiatric condition. Conclusions: This study provides further independent support for RBD as a clinically significant syndrome that could not be significantly explained as a prodrome or residual of major affective disorders.
Los estilos APA, Harvard, Vancouver, ISO, etc.

Capítulos de libros sobre el tema "Recurrent brief depression"

1

Floresco, Stan, Robert Kessler, Ronald L. Cowan, Robert Kessler, Ronald L. Cowan, Mark Slifstein, Andrea Cipriani et al. "Recurrent Brief Depression". En Encyclopedia of Psychopharmacology, 1142. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_3525.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Baldwin, David S. y Julia M. Sinclair. "Recurrent brief depression". En Troublesome disguises, 100–113. Chichester, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118799574.ch8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Angst, J. "Recurrent Brief Psychiatric Syndromes: Hypomania, Depression, Anxiety and Neurasthenia". En Basic and Clinical Science of Mental and Addictive Disorders, 33–38. Basel: KARGER, 1997. http://dx.doi.org/10.1159/000059530.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Angst, J. "Epidemiologie von „recurrent brief“ und „major depression“ — Resultate der Zürich-Studie". En Phantasie und Wirklichkeit — Fluvoxamin, 83–87. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-76935-1_6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Floresco, Stan, Robert Kessler, Ronald L. Cowan, Robert Kessler, Ronald L. Cowan, Mark Slifstein, Andrea Cipriani et al. "Recurrent Brief Depressive Disorder". En Encyclopedia of Psychopharmacology, 1142–44. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_376.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Bartova, Lucie y Lukas Pezawas. "Recurrent Brief Depressive Disorder". En Encyclopedia of Psychopharmacology, 1–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27772-6_376-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Bartova, Lucie y Lukas Pezawas. "Recurrent Brief Depressive Disorder". En Encyclopedia of Psychopharmacology, 1456–59. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-36172-2_376.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Angst, Jules, Alex Gamma, Valadeta Ajdacic, Dominique Eich, Lukas Pezawas y Wulf Rössler. "Recurrent brief depression as an indicator of severe mood disorders". En Bipolar Disorders, 109–30. Cambridge University Press, 2005. http://dx.doi.org/10.1017/cbo9780511544019.006.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Lipsey, John R. "Antidepressants". En Psychiatric Aspects of Neurologic Diseases. Oxford University Press, 2008. http://dx.doi.org/10.1093/oso/9780195309430.003.0023.

Texto completo
Resumen
Antidepressant drug therapy is the cornerstone of treatment for major depression and is usually successful (Rosenbaum et al., 2005). Fifty percent of patients respond to the first antidepressant used, and 75% respond to one of the first three agents chosen if these agents represent different antidepressant classes. Insufficient dosage and duration of therapy are the most common causes of treatment failure. The required duration for a full therapeutic trial of any antidepressant is 6 to 8 weeks, but some patients require 10 to 12 weeks to achieve maximum benefit. Every patient being treated pharmacologically for depression should be educated about the course of recovery. Even if an antidepressant is ultimately successful, improvement in the first week or two may be minimal and involve primarily improved sleep or diminished anxiety. When more substantial improvements begin later, they may vary greatly on a day-to-day basis, and patients should be forewarned that the early course of recovery may be punctuated by unexpected brief dips in mood. Patients may also find that their energy, appetite, activity level, and social engagement improve before they notice a positive change in their moods. Thus, they look much improved to their friends and families before they feel better. Eventually, however, the full range of depressive symptoms resolves, and this improvement is sustained. During the course of antidepressant treatment, all patients must be asked about new or recurrent suicidal ideas, and their families should be told to report any evidence of self-harming actions or thoughts. Suicidal ideas, perhaps held in check by lack of energy to carry them out, may potentially develop into suicidal impulses or actions if a patient’s energy improves while severely depressed mood or hopelessness persist. Five classes of antidepressants will be described below: selective serotonin reuptake inhibitors (SSRIs), the serotonin norepinephrine reuptake inhibitor (SNRI) venlafaxine, the alpha2-adrenergic antagonist mirtazapine, the norepinephrinedopamine reuptake inhibitor (NDRI) bupropion, and tricyclic antidepressants (TCAs). There is little evidence that any individual antidepressant (or antidepressant class) is generally superior to another, so the sequence of drug selection is determined primarily by tolerability and safety considerations. The SSRIs are commonly used in the initial treatment of major depression.
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Huys, Quentin J. M. "A Valuation Framework for Emotions Applied to Depression and Recurrence". En Computational Psychiatry. The MIT Press, 2016. http://dx.doi.org/10.7551/mitpress/9780262035422.003.0015.

Texto completo
Resumen
The burden of depression is substantially aggravated by relapses and recurrences, and these become more inevitable with every episode of depression. This chapter describes how computational psychiatry can provide a normative framework for emotions and an integrative approach to core cognitive components of depression and relapse. Central to this is the notion that emotions effectively imply a valuation; thus they are amenable to description and dissection by reinforcement-learning methods. It is argued that cognitive accounts of emotion can be viewed in terms of model-based valuation, and that automatic emotional responses relate to model-free valuation and the innate recruitment of fixed behavioral patterns. This model-based view captures phenomena such as helplessness, hopelessness, attributions, and stress sensitization. Considering it in more atomic algorithmic detail opens up the possibility of viewing rumination and emotion regulation in this same normative framework. The problem of treatment selection for relapse and recurrence prevention is outlined and suggestions made on how the computational framework of emotions might help improve this. The chapter closes with a brief overview of what we can hope to gain from computational psychiatry.
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Recurrent brief depression"

1

ANGST, J. y B. HOCHSTRASSER. "RECURRENT BRIEF DEPRESSION". En IX World Congress of Psychiatry. WORLD SCIENTIFIC, 1994. http://dx.doi.org/10.1142/9789814440912_0061.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Recurrent brief depression" para tipos de fuentes particulares:
Artículos de revistas
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía